Month: April 2018

Travel & Tourism Taiwan Industry Guide 2018-2024

Travel & Tourism Taiwan Industry Guide 2018-2024

Globe Market Reports

Single User License

$900.00

Taiwan will attract more than 12 Million international travelers and generated US$ 16 Billion revenues by 2024.
The report “Taiwan International Travelers Visitation, Spending Analysis 2012 – 2017 and Future Forecast 2018 – 2024” offers the most up-to-date industry data on the actual market situation and future outlook for Taiwan inbound tourism market. The report uses data and analysis to discuss future trends related to international travelers arrivals, spending, purpose of visits and main destination markets. The report provides clear insight into current and future tourism developments in the region. Furthermore, this report uses regional and country focused analysis to explore inbound tourist markets in Taiwan.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=121
A detailed country-wise analysis of the market is provided, covering a total of 15 nations and 5 regions. The research study limelight growth drivers and investigates market inhibitors of Taiwan travel & tourism.
The countries included in this report are Hong Kong & Macao, Mainland China, Japan, Malaysia, Singapore, Philippines, Canada, United States, France, Germany, Netherlands, United Kingdom, Australia, New Zealand and South Africa
The regions included in this report are Asia, North America, Oceania, Europe and Africa
Key Findings:
• Mainland China is the largest source market for Taiwan tourism, but its share will
   decline in the forecast period
• Hong Kong and Macau will be leading source market with nearly 20% share by 2024
• International tourists most commonly travel to the Taiwan for pleasure purposes
 The Latest Industry Data Included in this Report:
• Total International Travelers in Taiwan & Forecast (2012 – 2024)
• Total International Travelers Spending in Taiwan & Forecast (2012 – 2024)
• Total International Travelers Spending Share & Forecast (2012 – 2024)
• By Region Travelers Spending Share & Forecast (2012 – 2024)
• 5 Region Travelers Visitation, Spending & Forecast (2012 – 2024)
• 5 Region Travelers Purpose of Visit & Forecast (2012 – 2024)
• 15 Countries Travelers Visitation & Forecast (2012 – 2024)
• 15 Countries Travelers Purpose of Visit & Forecast (2012 – 2024)
• 15 Countries Travelers Spending & Forecast (2012 – 2024)
• Identification of Key Drivers and Inhibitors of the Taiwan Travel & Tourism

Advertisements
Proton Therapy Market US Projected to Grow at a CAGR of 15% by latest Trend, Share, Size, Application, Growth and Forecast to 2025

Proton Therapy Market US Projected to Grow at a CAGR of 15% by latest Trend, Share, Size, Application, Growth and Forecast to 2025

Globe Market Reports

Single User License

$1,200.00

“United States Proton Therapy Market (Actual & Potential), Patients Treated, Reimbursement, Clinical Trails, Proton Therapy Centers, Major Deals, Key Company Profiles & Demand Forecasts to 2018 – 2025” presents an in-depth assessment of the proton therapy market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends.  The report offers the most up-to-date industry data on the actual and potential market situation and future outlook for Proton Therapy in United States. The research includes historic data from 2012 to 2017 and forecasts until 2025.
Long–term Growth Projection:
• United States proton therapy market will exhibit growth by a CAGR of over 15% up to 2025
• United States is anticipated to be the most attractive market in the proton therapy market industry
• The potential United States proton therapy market is set to cross USD 7 Billion by 2025
• In 2017, IBA accounted highest number of proton therapy centers in United States
• Hitachi has the second highest number of treatment rooms in United States
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers.
The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.
The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies, recent development & trends of the proton therapy market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Hitachi, Optivus, Ion Beam Applications(IBA), Varian Medical Systems, Mevion Medical Systems
The Latest Industry Data Included in this Report:
• Proton Therapy Market Size & Analysis (2012 – 2025)
• Proton Therapy Market Opportunity Assessment (2012 – 2025)
• Number of Treatment Rooms and Forecast (2012 – 2025)
• Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• Major Deals in Proton Therapy Market
• Number of Patients Treated at Proton Therapy Center
• Proton Therapy Reimbursement Scenario
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Key Market Drivers and Inhibitors
• Major Companies Analysis

United States Insulin Delivery Market Competitive Landscape, Changing Market Trends and Emerging Opportunities

United States Insulin Delivery Market Competitive Landscape, Changing Market Trends and Emerging Opportunities

Globe Market Reports

Single User License

$900.00

United States Insulin Delivery Devices Market is anticipated to surpass US$ 6 Billion by 2022.
Growth in US insulin delivery devices market can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, user–friendly design, help avoid over/under–dosing of insulin, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin delivery devices.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=120
The report titled “United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States insulin pump and insulin pen market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2022. A comprehensive analysis has been done on market share of insulin delivery devices segment.
The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population in United States. It provides essential insights into total insulin delivery users, insulin pump users and insulin pen users with more focused–on reusable and prefilled insulin pen users.
The report further sheds light on detailed US reimbursement scenario of insulin pump and insulin pen. Additionally, the report includes assessment of preferred insulin pump brand by the patients. The report also explores detailed description of growth drivers and inhibitors of the United States insulin delivery market.
The report concludes with the profiles of major players in the insulin delivery devices market such as Insulet Corporation, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product portfolios and latest development and trends of the insulin delivery devices market.
Key Highlights of the United States Insulin Delivery Devices Market Report: 
• Diabetes Population (2011 – 2022)
• Overall Insulin Delivery Users Snapshot (2011 – 2022)
• Insulin Pump Users (2011 – 2022)
• Type 1 Diabetes Insulin Pump Users (2011 – 2022)
• Type 2 Diabetes Insulin Pump Users (2011 – 2022)
• Insulin Pen Users (2011 – 2022)
• Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
• Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
• Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share (2011 – 2022)
• Overall Insulin Delivery Devices:  Market Snapshot (2011 – 2022)
• Insulin Pump Market Size (2011 – 2022)
• Insulin Pen Market Size (2011 – 2022)
• Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
• Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
• Insulin Delivery Devices Segment (Insulin Pump & Insulin Pen) Market Share (2011 – 2022)
• Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share (2011 – 2022)
• Insulin Pump Preferred Brand – By Product (2011 – 2022)
• Insulin Pump and Pen Reimbursement Scenario (2011 – 2022)
• Key Drivers and Inhibitors of the Insulin Delivery Devices Market
• Key Companies Analysis
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Insulet Corporation
• Medtronic
• Roche
• Tandem Diabetes Care
• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford
Key Deliverables in the Study
• Market Definition for the specified topic along with identification of key drivers and inhibitors for the market
• Trending factors influencing the market shares of the United States Insulin Delivery Devices
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides a five-year forecast which helps to provide a long-term assessment of developments in the United States Insulin Delivery Devices Market.
• Identification and Analysis of the Macro and Micro factors that affect the United States Insulin Delivery Devices Market
• Identification of factors instrumental in changing the market scenarios, rising prospective opportunities
• A comprehensive list of key market players along with the analysis of their current product portfolios and recent development

United States Proton Therapy Market Research Report 2018, Market Overview and Forecast up to 2025

United States Proton Therapy Market Research Report 2018, Market Overview and Forecast up to 2025

Globe Market Reports

Single User License

$900.00

United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$ 7 Billion by 2025.
Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers, decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period.
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=119
The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of US proton therapy center (installed base) and treatment room by company. The report also provides information on the proton therapy current applications and comparative analysis with more focused on pros and cons of proton therapy and competitive analysis of eight companies.
The report further sheds light on the number of treatment rooms, current and upcoming proton therapy centers. In addition, the report also provides essential insights on number of patients treated at US proton therapy centers from 2008 to 2015.
The report also includes assessment of US reimbursement scenario, proton therapy clinical trials and offers a clear view of the proton therapy center component analysis. Key trends in terms of venture capital investment, collaborations, partnerships, licensing and development agreements are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the US proton therapy market.
The report concludes with the profiles of major players in the US proton therapy market. The key market players are evaluated on various parameters such as company overview, product portfolio, US proton therapy centers developed by the companies and recent development & trends of the proton therapy market.
Key Highlights of the United States Proton Therapy Market Report: 
• Proton Therapy Current Applications
• Pros and Cons of Proton Therapy, Radiotherapy and Carbon Ion Therapy
• Proton Therapy Competitive Analysis: By Company
• Market Size & Analysis: United States Proton Therapy (2012 – 2025)
• Market Opportunity Assessment: United States Proton Therapy (2012 – 2025)
• United States Number of Treatment Rooms and Forecast (2012 – 2025)
• United States Proton Therapy Center (Installed Base) and Treatment Room Market Share: By Company
• United States Proton Therapy Center Infrastructure Analysis: Treatment Rooms & Proton Therapy Accelerator
• United States Number of Patients Treated at Proton Therapy Centers (2008 – 2015)
• United States Proton Therapy Reimbursement Scenario
• Proton Therapy Center Component Analysis
• Proton Therapy Clinical Trail Insight by Phase, Institute & Country
• Proton Therapy Market – Major Deals
• Key Market Drivers and Inhibitors of the United States Proton Therapy Market
• Major Companies Analysis
Key Companies Covered in the Report are as follows:
• Optivus
• Hitachi
• Ion Beam Applications(IBA)
• Varian Medical Systems
• Mevion Medical Systems

US Pediatric Vaccines Market Estimated To Reach $15 Billion By 2025

US Pediatric Vaccines Market Estimated To Reach $15 Billion By 2025

Globe Market Reports
United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, growing public acceptance, increasing government focus on immunization programs and increased government funding for the vaccines development.
“Pediatric Vaccines Market: United States Industry Analysis, Trends, Opportunity, Market Size and Segment Forecasts, 2018 – 2025” provides a unique tool for evaluating the market, highlighting opportunities, supporting strategic and tactical decision–making. This report recognizes that in this rapidly–evolving and competitive environment, up–to–date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on trends and developments and focuses on United States pediatric vaccines market. The report also provides clear insight into current and future developments of the United States pediatric vaccines market. Furthermore, this report provides a deep and thorough evaluation of the top 10 pediatric vaccines by disease indication. On the basis of disease indication, the top 10 pediatric vaccines provide an in-depth analysis of doses administered, number of children being vaccinated and market size. The research includes historic data from 2010 to 2017 and forecasts until 2025.
The report also explores detailed description of growth drivers and inhibitors of the United States pediatric vaccines market.
The report concludes with the profiles of major players in the United States pediatric vaccines market. The key market players are evaluated on various parameters such as company overview, pediatric vaccines portfolios and latest development & trends of the pediatric vaccines market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
• Sanofi Pasteur
• GlaxoSmithKline(GSK)
• Merck & Co.
• Pfizer Inc
• Grifols
Major Pediatric Vaccines (Disease Indication) Covered Under This Report Are:
• Diphtheria, Tetanus & Pertussis (DTap)
• Hepatitis A
• Varicella/Chicken Pox
• Pneumococcal
• Haemophilus Influenzae Type B (HIB)
• Polio
• Rotavirus
• Hepatitis B
• Influenza Pediatric
• Measles, Mumps & Rubella (MMR)
The Latest Industry Data Included in this Report:
• United States Pediatric Vaccines Market Size & Analysis ,2010 – 2025
• United States Pediatric Vaccines Market Share and Y–o–Y Growth (%),2010 – 2025
• United States Pediatric Vaccines Market by Disease Indication ,2010 – 2025
• 10 Pediatric Vaccines Doses Administered (Volume),2010 – 2025
• Number of Children Being Vaccinated (Volume)2010 – 2025
• 10 Pediatric Vaccines Market Size and Forecast(Value),2010 – 2025
• Key Market Drivers and Inhibitors of the United States Pediatric Vaccines Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
   Product Portfolios and Latest Recent Development and Trends
The Following Key Questions have been Addressed in the Report:
• What is the size of the United States pediatric vaccines market during 2010 -2025?
• How will each segment of the United States pediatric vaccines market grow during the forecast
   period and what will be the revenue generated by each of the segments by the end of 2025?
• Which major pediatric vaccines provides highest market share?
• How much number of children being vaccinated during 2010 – 2025?
• How are the overall market and segments types growing?
• What are the major market drivers and inhibitors in the United States pediatric vaccines market?
• Who are the key players in the United States pediatric vaccines market and what are their contributions?
Supplemental Biologics License Application for .5 mL Influenza Vaccine in Children 6-35 Months Accepted by FDA

Supplemental Biologics License Application for .5 mL Influenza Vaccine in Children 6-35 Months Accepted by FDA

Globe Market Reports

Source: http://www.contagionlive.com/

The US Food and Drug Administration (FDA) accepted for review a supplemental Biologics License Application seeking to expand the age indication of the 0.5 mL dose of Sanofi Pasteur’s influenza vaccine (Fluzone Quadrivalent) to include children between 6 and 35 months of age.

The target action date is January 28, 2019, per the Prescription Drug User Fee Act.

“We are one step closer to potentially offering clinicians the option to use 0.5 mL dose of Fluzone Quadrivalent vaccine with all of their eligible pediatric patients 6 months of age and older,” David Greenberg, MD, associate vice president and regional medical head of North American, Sanofi Pasteur, said in a statement.

Visit for More Reports on Pediatric Vaccine: http://www.dpiresearch.com/

Non Invasive Prenatal Testing 2017 China Industry Key Players – Berry Genomics, BGI Diagnostic Co., Ltd, Basetra Market Analysis And Forecast To 2024

Non Invasive Prenatal Testing 2017 China Industry Key Players – Berry Genomics, BGI Diagnostic Co., Ltd, Basetra Market Analysis And Forecast To 2024

Globe Market Reports

Single User License

$900.00

China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.
Long–term Growth Projection and Development:
• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market
Browse full table of contents and data tables at : http://www.dpiresearch.com/report-details.php?P_ID=113
Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.
The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.
The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.
The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.
Key Topics Covered in the Report
• 2013 – 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 – 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market
Key Companies Covered in the Report are as follows:
• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra